Literature DB >> 15188028

The pattern of cytokine gene expression in human colorectal carcinoma.

Anna Csiszár1, Tamás Szentes, Bea Haraszti, Annamária Balázs, Gyôzô G Petrányi, Eva Pócsik.   

Abstract

Systemic and local cytokine environment may modulate the immunogenicity of colorectal cancer cells, and affect anti-tumor immune functions of tumor-infiltrating lymphocytes. We therefore investigated cytokine mRNA expression patterns in tumors and peripheral blood mononuclear cells (PBMC) from patients with colorectal adenocarcinoma. IL-2, IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-4, IL-6, IL-8, IL-10 and IL-1 beta mRNAs in single cell suspension of freshly isolated colorectal cancer tissue were studied by RT-PCR. Frequencies of cytokine gene expression were compared to those in normal colonic mucosa from tumor patients. The frequencies of IL-2, IFN-gamma, IL-4 and IL-10 gene expression were also determined in peripheral blood mononuclear cells from patients with colorectal adenocarcinoma and compared to those of healthy individuals. Tumor samples were more frequently positive for IFN-gamma, IL-2, TNF-alpha and IL-10 gene expression than normal mucosa (p=0.0001, p=0.0118, p=0.001 and p<0.0001, respectively). Frequencies of IL-2 and TNF-alpha gene expressions were significantly higher in tumors with a diameter <5 cm, than in those with a diameter >5 cm. The genes for IL-6, IL-1 beta and IL-8 were commonly expressed in both tumor tissue and normal colonic mucosa. IFN-gamma transcripts were detected in more PBMC samples from patients with colorectal cancer than those from normal controls (p=0.0449). Thus, colorectal cancer tissue is characterized by a specific pattern of cytokine gene expression. It is likely that multiple interactions between pro- and anti-inflammatory cytokines regulate tumor growth and the functional activity of tumor-infiltrating lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188028     DOI: 10.1007/BF02893465

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   2.874


  54 in total

1.  Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes.

Authors:  M J Maeurer; W Walter; D Martin; L Zitvogel; E Elder; W Storkus; M T Lotze
Journal:  Scand J Immunol       Date:  1997-02       Impact factor: 3.487

2.  Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience.

Authors:  S Huang; S E Ullrich; M Bar-Eli
Journal:  J Interferon Cytokine Res       Date:  1999-07       Impact factor: 2.607

3.  Endogenous TNF inducibility and prognosis of colorectal cancer.

Authors:  K Takagi; K Tomita; Y Fukushima; A Chikamoto; J Kanou; T Honda; H Yoshimura; R Nozaki; K Tashiro; G Soma
Journal:  Anticancer Res       Date:  1998 Nov-Dec       Impact factor: 2.480

Review 4.  Immunological and biochemical modulation in the treatment of advanced colorectal cancer: update and future directions.

Authors:  R U Hilgenfeld; E D Kreuser
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

5.  The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma.

Authors:  S Coca; J Perez-Piqueras; D Martinez; A Colmenarejo; M A Saez; C Vallejo; J A Martos; M Moreno
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

6.  Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies.

Authors:  F De Vita; M Orditura; G Galizia; C Romano; S Infusino; A Auriemma; E Lieto; G Catalano
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

Review 7.  Biological implications of macrophage infiltration in human tumor angiogenesis.

Authors:  M Ono; H Torisu; J Fukushi; A Nishie; M Kuwano
Journal:  Cancer Chemother Pharmacol       Date:  1999       Impact factor: 3.333

8.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

Authors:  Y Naito; K Saito; K Shiiba; A Ohuchi; K Saigenji; H Nagura; H Ohtani
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

9.  Effect of irinotecan on the phenotype of peripheral blood leukocyte populations in patients with metastatic colorectal cancer.

Authors:  Bohuslav Melichar; Miroslava Touskova; Pavel Vesely
Journal:  Hepatogastroenterology       Date:  2002 Jul-Aug

10.  Selective suppression of cytokine secretion in whole blood cell cultures of patients with colorectal cancer.

Authors:  H Lahm; M Schindel; L Frikart; J P Cerottini; A Yilmaz; J C Givel; J R Fischer
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more
  20 in total

1.  Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages.

Authors:  Omar A Al Obeed; Khayal A Alkhayal; Abdulmalik Al Sheikh; Ahmad M Zubaidi; Mansoor-Ali Vaali-Mohammed; Robin Boushey; James H Mckerrow; Maha-Hamadien Abdulla
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.

Authors:  Shusaku Ohira; Motoko Sasaki; Kenichi Harada; Yasunori Sato; Yoh Zen; Kumiko Isse; Kazuto Kozaka; Akira Ishikawa; Koji Oda; Yuji Nimura; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

3.  Preincisional versus postincisional administration of parecoxib in colorectal surgery: effect on postoperative pain control and cytokine response. A randomized clinical trial.

Authors:  Ageliki Pandazi; Evagelia Kapota; Paraskevi Matsota; Pinelopi Paraskevopoulou; Christos Dervenis; Georgia Kostopanagiotou
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

4.  Management of immune thrombocytopoenia in a patient with newly-diagnosed smouldering myeloma and colorectal cancer.

Authors:  Agostina Siniscalchi; Roberto Stasi; Stefano Fratoni; Paolo de Fabritiis; Tommaso Caravita
Journal:  BMJ Case Rep       Date:  2009-06-11

5.  Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.

Authors:  Nikolaos I Nikiteas; Nikolaos Tzanakis; Maria Gazouli; George Rallis; Kessaris Daniilidis; George Theodoropoulos; Alkiviadis Kostakis; George Peros
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

6.  Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  G Bobe; G Murphy; P S Albert; L B Sansbury; E Lanza; A Schatzkin; N H Colburn; A J Cross
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

7.  Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer.

Authors:  Hao Wang; Hong-Sheng Wang; Bin-Hua Zhou; Cui-Lin Li; Fan Zhang; Xian-Feng Wang; Ge Zhang; Xian-Zhang Bu; Shao-Hui Cai; Jun Du
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

8.  Initiation of Pancreatic Cancer: The Interplay of Hyperglycemia and Macrophages Promotes the Acquisition of Malignancy-Associated Properties in Pancreatic Ductal Epithelial Cells.

Authors:  Lilli Otto; Sascha Rahn; Tina Daunke; Frederik Walter; Elsa Winter; Julia Luisa Möller; Stefan Rose-John; Daniela Wesch; Heiner Schäfer; Susanne Sebens
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

9.  The Effects of Isoproterenol and Propranolol on Cytokine Profile Secretion by Cultured Tumor-infiltrating Lymphocytes Derived from Colorectal Cancer Patients.

Authors:  Shahram Seyedi; Alireza Andalib; Abbas Rezaei; Seyed Mohsen Hosseini; Seyed Reza Mohebbi; Mohammad Reza Zali; Mohamad Vafai; Roubik Behboo; Seyed Abbas Tabatabaei; Shahram Shahabi
Journal:  Cell J       Date:  2011-12-22       Impact factor: 2.479

10.  Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract.

Authors:  Fiorella Biasi; Tina Guina; Marco Maina; Mario Nano; Alessandro Falcone; Emiliano Aroasio; Giorgio Maria Saracco; Mauro Papotti; Gabriella Leonarduzzi; Giuseppe Poli
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.